Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.
AUTOR(ES)
Khamashta, M A
RESUMO
Because thrombocytopenia occurs frequently in patients with anticardiolipin (aCL) antibodies and thrombosis, some investigators have proposed that aCL antibodies may play a direct part in thrombosis by binding and activating platelets. To test this proposal experiments were performed to determine whether aCL antibodies can bind platelets. Preincubation of aCL positive sera with freeze-thawed platelets caused significant inhibition of aCL activity in four serum samples tested. Antibodies with cardiolipin binding activity were subsequently eluted from these platelets. Total phospholipids extracted from platelets inhibited aCL activity, and the specific phospholipids bound were shown to be phosphatidylethanolamine, phosphatidylserine, and phosphatidylinositol. It is concluded that aCL antibodies can bind phospholipids in platelet membranes but pertubation of the membrane must first occur.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1003615Documentos Relacionados
- Toll‐like receptor and antiphospholipid mediated thrombosis: in vivo studies
- Increased Fluidity of Human Platelet Membranes during Complement-Mediated Immune Platelet Injury
- Bomebesin: specific binding to rat brain membranes.
- Studies on human platelet granules and membranes.
- Binding of bovine factor Va to phosphatidylcholine membranes.